local_hospital

AOU Ospedali Riuniti Umberto I°-Lancisi-Salesi di Ancona

Address
via Conca 71, 60126 Torrette (AN), Ancona, Italy

AOU Ospedali Riuniti Umberto I°-Lancisi-Salesi di Ancona

AOU Ospedali Riuniti Umberto I°-Lancisi-Salesi di Ancona is a comprehensive academic medical center conducting advanced clinical research across multiple therapeutic areas. The center demonstrates particular expertise in cardiovascular diseases, oncology, and hematological disorders, with a strong emphasis on precision medicine and genotype-environment interactions in disease management.

  • Cardiovascular inflammation studies, including acute myocarditis and inflammatory cardiomyopathy with novel corticosteroid and colchicine therapies
  • Precision oncology in EGFR-mutant non-small cell lung cancer, investigating targeted therapies based on TP53 mutational status
  • Hematologic malignancies and venous thromboembolism, focusing on myelodysplastic syndromes and thrombosis prevention in elderly populations

The institution's research portfolio reflects a commitment to addressing complex medical conditions through innovative therapeutic approaches. Their trials investigate targeted molecular therapies in lung cancer, immunomodulatory treatments for severe cardiac inflammation, and novel strategies for managing transfusion-dependent anemia in myelodysplastic syndromes with chromosome 5q deletion. The center also leads important work in thrombosis prevention, particularly focusing on elderly patients at risk for recurrent venous thromboembolism, demonstrating a comprehensive approach to both acute and chronic disease management.

Site Overview

assignment
5
connected trials
corporate_fare
4
sponsors
science
6
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
4
Sponsors (total)
4
Active sponsors
3

Sponsor Network

Top 3 by active trials.

lock +2 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 566 other sites in Italy

description
Trial volume
5
Outperforms 58% of sites
public
Therapeutic diversity
3areas
Outperforms 57% of sites
groups
Sponsor diversity
4sponsors
Outperforms 55% of sites

Therapeutic Area Benchmark — Italy

Select a therapeutic area to compare against other sites in Italy.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Italy

Market Share

Country: Italy

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in AOU Ospedali Riuniti Umberto I°-Lancisi-Salesi di Ancona

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy of Colchicine in Treating Inflammatory Cardiomyopathy: A Single-Blinded, Randomized, Controlled TrialASST Grande Ospedale Metropolitano NiguardaPhase IIINot Yet Recruiting

IMP list

lock Showing 1 of 6 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Colchicine1Unknown

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.